Two large PrEP studies using two-month infusion of antibodies to prevent HIV infection: oral PrEP included for all participants
1 August 2016. Related: HIV prevention and transmission.
HIV prevention and transmission
Preventive technologies: antiretroviral and vaccine development
14 July 2016. Related: Pipeline report, Antiretrovirals, HIV prevention and transmission, Vaccines and microbicides.
NHS England confuses arse and elbow: block to PrEP ignores UK HIV crisis and will send PEP services into chaos
2 June 2016. Related: Treatment alerts, Treatment access, HIV prevention and transmission.
Dramatic increase in use of oral TDF/FTC for PrEP in the US – plus a few cautions
22 March 2016. Related: Conference reports, HIV prevention and transmission.
Future oral and long-acting formulations for PrEP: pills, films, gels, injections and depots
22 March 2016. Related: Conference reports, HIV prevention and transmission.
First data on TAF as PrEP to prevent HIV infection
22 March 2016. Related: Conference reports, HIV prevention and transmission.
Long-acting cabotegravir as PrEP protects macaques against IV exposure but will need two-monthly injections
22 March 2016. Related: Conference reports, HIV prevention and transmission.
Role for maraviroc as HIV PrEP likely to need dual combinations
22 March 2016. Related: Conference reports, HIV prevention and transmission.
Dapivirine PrEP vaginal ring shows only limited PrEP protection against HIV in African women
22 March 2016. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Canada approves TDF/FTC as PrEP
22 March 2016. Related: HIV prevention and transmission.
NHS England pulls proposed timeline for PrEP: perpetuates HIV health crisis in gay men and trans people
22 March 2016. Related: HIV prevention and transmission.
UK community campaign calls for NHS England to be accountable for PrEP timeline
22 March 2016. Related: HIV prevention and transmission.
European application underway for PrEP indication for tenofovir/FTC
1 February 2016. Related: HIV prevention and transmission.
VAT may be payable when importing generic medicines in to the UK
1 February 2016. Related: HIV prevention and transmission.
South African Medicines Control Council approves tenofovir/FTC for PrEP
1 February 2016. Related: HIV prevention and transmission.
Two cases of HIV transmission on tenofovir DF monotherapy
1 February 2016. Related: HIV prevention and transmission.
HIV rates still increasing in gay men: 2015 report
1 December 2015. Related: HIV prevention and transmission, Other news.
PrEP to be available free in France from January 2016
1 December 2015. Related: HIV prevention and transmission.
PrEP efficacy for transgender women: new analysis from iPrEX study
1 December 2015. Related: HIV prevention and transmission.
PrEP in a clinical setting: no infections reported in San Francisco cohort
1 December 2015. Related: HIV prevention and transmission.
New free self-sampling HIV home testing service launched in England
1 December 2015. Related: HIV prevention and transmission.
No transmission of integrase-resistant HIV seen in California cohort
1 October 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission, Drug resistance.
The PrEP experience: IAS 2015 and beyond
1 October 2015. Related: Conference reports, HIV prevention and transmission.
i-Base Q&A resources on PrEP: increased use of off-label PrEP in the UK shows need for NHS support and risk to PEP services
1 October 2015. Related: HIV prevention and transmission.
Two new UK community PrEP websites
1 October 2015. Related: HIV prevention and transmission, On the web.
First UK NHS PrEP support service launched at 56 Dean Street, Soho
1 October 2015. Related: HIV prevention and transmission.
UK PROUD study published as open access article in The Lancet: PrEP dramatically reduces risk of HIV
1 October 2015. Related: HIV prevention and transmission.
Four reasons IAS 2015 will be a milestone HIV conference: a personal view
1 August 2015. Related: Conference reports, Antiretrovirals, Treatment strategies, HIV prevention and transmission.
HPTN 052: no HIV transmissions on effective ART but only limited data on viral failure and drug resistance
1 August 2015. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Rectal STIs and viral load in HIV positive men on and off ART
1 June 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Methmephangee – ChemSex vs recreational drug use: a proposed definition for health workers
1 June 2015. Related: HIV prevention and transmission.
No HIV transmissions between gay couples when viral load is undetectable: preliminary results from “Opposites Attract” study in Australia, Thailand and Brazil
24 March 2015. Related: Conference reports, HIV prevention and transmission.
PrEP reduced HIV risk by at least 86% in PROUD: no transmissions likely from people taking meds
24 March 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
“On demand” PrEP dosing in IPERGAY: 86% reduced risk of HIV, no transmissions with active drug use
24 March 2015. Related: Conference reports, HIV prevention and transmission.
Other HIV PrEP studies at CROI 2015: implementation of oral PrEP and problems with tenofovir gel
24 March 2015. Related: Conference reports, HIV prevention and transmission.
HIV prevention budget for 2015 slashed by 50%, then rapidly reinstated
29 January 2015. Related: HIV prevention and transmission.
Grassroots demand grows for early access to PrEP in the UK
29 January 2015. Related: HIV prevention and transmission.
New York announces new policy to dramatically reduce HIV incidence by 2020
29 January 2015. Related: HIV prevention and transmission.
UK PROUD study to provide PrEP to all participants earlier than expected: planned follow-up to continue to two years
1 December 2014. Related: HIV prevention and transmission.
IPERGAY PrEP study shows early efficacy in protecting gay men from HIV: all participants to switch to active drug
1 December 2014. Related: HIV prevention and transmission.
HIV in the UK 2014: Public Health England report on incidence and care
1 December 2014. Related: HIV prevention and transmission, Other news.
UK PROUD study to provide PrEP earlier than expected: planned follow-up to continue to two years
16 October 2014. Related: HIV prevention and transmission, Research studies.
Antiretroviral studies at ICAAC 2014: darunavir-based FDC with TAF, cobicistat, doravirine, Stribild and gel formulation PrEP
1 October 2014. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Update on baseline STIs in UK oral PrEP study (PROUD)
1 October 2014. Related: Conference reports, HIV prevention and transmission.
HIV reinfection has limited impact on disease progression
1 October 2014. Related: HIV prevention and transmission.
Higher ART coverage is associated with lower HIV infection rates in a multi-country analysis
1 August 2014. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Open label oral PrEP at four doses a week: why zero infections does not equal 100% efficacy
1 August 2014. Related: Conference reports, HIV prevention and transmission.
Preventive technologies: antiretroviral and vaccine development
19 July 2014. Related: Pipeline report, Antiretrovirals, HIV prevention and transmission, Vaccines and microbicides.
No HIV transmissions with undetectable viral load: interim PARTNER study results show need for longer follow-up
24 March 2014. Related: Conference reports, HIV prevention and transmission.
PrEP injections every three months may protect against exposure from anal sex
24 March 2014. Related: Conference reports, HIV prevention and transmission.
The little blue pill that can stop HIV: PROUD study enrolling gay men in the UK
1 December 2013. Related: HIV prevention and transmission.
Persistence of transmitted drug resistance mutations suggests source partners may be treatment-naive
1 October 2013. Related: HIV prevention and transmission, Drug resistance.
HIV self testing to become legal in the UK from April 2014
1 October 2013. Related: HIV prevention and transmission.
Agreement to develop long-acting rilpivirine as PrEP
1 October 2013. Related: HIV prevention and transmission.
Use of ART at baseline by treatment naïve patients in HPTN-052
1 October 2013. Related: HIV prevention and transmission.
Partner-dependent immune differences may protect against HIV infection
25 July 2013. Related: Conference reports, HIV prevention and transmission.
Bangkok Tenofovir Study: US CDC recommends oral PrEP for injecting drug users – based on 16 fewer infections over 5 years
25 July 2013. Related: HIV prevention and transmission.
Preventive technologies, research toward a cure, and immune-based and gene therapies
30 June 2013. Related: Pipeline report, HIV prevention and transmission, Cure-related research.
Monthly injection protects macaques from rectal exposure: results should fast-track human studies for advanced PrEP options
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Tenofovir DF ring protects macaques from vaginal exposure
1 April 2013. Related: Conference reports, HIV prevention and transmission.
VOICE study reports low adherence as reason for lack of efficacy for PrEP: anal sex common in African heterosexuals
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Further studies on how male circumcision may reduce HIV transmission
1 April 2013. Related: Conference reports, HIV prevention and transmission.
Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load
1 February 2013. Related: Conference reports, Women's health, HIV prevention and transmission.
UK group describe risk of HIV transmission for people on effective ART as “extremely low”
1 February 2013. Related: HIV prevention and transmission.
CDC issues brief on the prevention benefits of HIV treatment
1 February 2013. Related: HIV prevention and transmission.